Capstone Investment Advisors’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Hold |
51,190
| – | – | ﹤0.01% | 825 |
|
|
2025
Q1 | $161K | Hold |
51,190
| – | – | ﹤0.01% | 499 |
|
|
2024
Q4 | $222K | Hold |
51,190
| – | – | ﹤0.01% | 646 |
|
|
2024
Q3 | $137K | Hold |
51,190
| – | – | ﹤0.01% | 726 |
|
|
2024
Q2 | $114K | Hold |
51,190
| – | – | ﹤0.01% | 967 |
|
|
2024
Q1 | $273K | Hold |
51,190
| – | – | ﹤0.01% | 1067 |
|
|
2023
Q4 | $75.8K | Hold |
51,190
| – | – | ﹤0.01% | 974 |
|
|
2023
Q3 | $71.2K | Hold |
51,190
| – | – | ﹤0.01% | 1047 |
|
|
2023
Q2 | $75.2K | Hold |
51,190
| – | – | ﹤0.01% | 797 |
|
|
2023
Q1 | $84.5K | Hold |
51,190
| – | – | ﹤0.01% | 501 |
|
|
2022
Q4 | $71.7K | Hold |
51,190
| – | – | ﹤0.01% | 604 |
|
|
2022
Q3 | $79K | Hold |
51,190
| – | – | ﹤0.01% | 683 |
|
|
2022
Q2 | $113K | Hold |
51,190
| – | – | ﹤0.01% | 627 |
|
|
2022
Q1 | $127K | Hold |
51,190
| – | – | ﹤0.01% | 758 |
|
|
2021
Q4 | $308K | Sell |
51,190
-1,159
| -2% | -$6.97K | ﹤0.01% | 515 |
|
|
2021
Q3 | $349K | Buy |
52,349
+1,159
| +2% | +$7.73K | ﹤0.01% | 577 |
|
|
2021
Q2 | $340K | Sell |
51,190
-6,030
| -11% | -$40.1K | ﹤0.01% | 466 |
|
|
2021
Q1 | $530K | Sell |
57,220
-67,568
| -54% | -$626K | ﹤0.01% | 292 |
|
|
2020
Q4 | $2.25M | Buy |
+124,788
| New | +$2.25M | 0.01% | 168 |
|